Leroux-Roels G - Search Results

1

Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Gouma S, Vermeire T, Van Gucht S, Martens L, Hutse V, Cremer J, Rota PA, Leroux-Roels G, Koopmans M, van Binnendijk R, Vandermarliere E. Gouma S, et al. Sci Rep. 2018 Sep 6;8(1):13337. doi: 10.1038/s41598-018-31630-z. Sci Rep. 2018. PMID: 30190529 Free PMC article.

2

Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.

de Vries RD, Nieuwkoop NJ, Pronk M, de Bruin E, Leroux-Roels G, Huijskens EGW, van Binnendijk RS, Krammer F, Koopmans MPG, Rimmelzwaan GF. de Vries RD, et al. Vaccine. 2017 Jan 5;35(2):238-247. doi: 10.1016/j.vaccine.2016.11.082. Epub 2016 Nov 30. Vaccine. 2017. PMID: 27914742

3

Publisher Correction: Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Gouma S, Vermeire T, Van Gucht S, Martens L, Hutse V, Cremer J, Rota PA, Leroux-Roels G, Koopmans M, van Binnendijk R, Vandermarliere E. Gouma S, et al. Sci Rep. 2020 Mar 20;10(1):5456. doi: 10.1038/s41598-020-62301-7. Sci Rep. 2020. PMID: 32198462 Free PMC article.

4

Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Desombere I, Willems A, Gijbels Y, Leroux-Roels G. Desombere I, et al. J Virol. 2006 Apr;80(7):3506-14. doi: 10.1128/JVI.80.7.3506-3514.2006. J Virol. 2006. PMID: 16537618 Free PMC article.

5

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

Leroux-Roels I, Borkowski A, Vanwolleghem T, Dramé M, Clement F, Hons E, Devaster JM, Leroux-Roels G. Leroux-Roels I, et al. Lancet. 2007 Aug 18;370(9587):580-9. doi: 10.1016/S0140-6736(07)61297-5. Lancet. 2007. PMID: 17707753 Clinical Trial.

6

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.

Vanwolleghem T, Bukh J, Meuleman P, Desombere I, Meunier JC, Alter H, Purcell RH, Leroux-Roels G. Vanwolleghem T, et al. Hepatology. 2008 Jun;47(6):1846-55. doi: 10.1002/hep.22244. Hepatology. 2008. PMID: 18452146

7

Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination.

Vandermeulen C, Clement F, Roelants M, Van Damme P, Hoppenbrouwers K, Leroux-Roels G. Vandermeulen C, et al. J Infect Dis. 2009 May 15;199(10):1457-60. doi: 10.1086/598482. J Infect Dis. 2009. PMID: 19320590

8

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.

Meuleman P, Bukh J, Verhoye L, Farhoudi A, Vanwolleghem T, Wang RY, Desombere I, Alter H, Purcell RH, Leroux-Roels G. Meuleman P, et al. Hepatology. 2011 Mar;53(3):755-62. doi: 10.1002/hep.24171. Epub 2011 Feb 11. Hepatology. 2011. PMID: 21319203 Free PMC article.

9

HIV vaccines: can CD4+ T cells be of help?

Van Braeckel E, Leroux-Roels G. Van Braeckel E, et al. Hum Vaccin Immunother. 2012 Dec 1;8(12):1795-8. doi: 10.4161/hv.21760. Epub 2012 Aug 21. Hum Vaccin Immunother. 2012. PMID: 22906935 Free PMC article.

10

Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.

Leroux-Roels G, Bourguignon P, Willekens J, Janssens M, Clement F, Didierlaurent AM, Fissette L, Roman F, Boutriau D. Leroux-Roels G, et al. Clin Vaccine Immunol. 2014 Mar;21(3):302-11. doi: 10.1128/CVI.00617-13. Epub 2014 Jan 3. Clin Vaccine Immunol. 2014. PMID: 24391139 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page